CATALYST PHARMACEUTICALS INC Earnings Dividend

CATALYST PHARMACEUTICALS INC’s revenue jumped 7.61% since last year same period to $152.61Mn in the Q4 2025. On a quarterly growth basis, CATALYST PHARMACEUTICALS INC has generated 2.84% jump in its revenue since last 3-months.

CATALYST PHARMACEUTICALS INC’s net profit fell -5.79% since last year same period to $52.7Mn in the Q4 2025. On a quarterly growth basis, CATALYST PHARMACEUTICALS INC has generated -0.16% fall in its net profits since last 3-months.

CATALYST PHARMACEUTICALS INC’s net profit margin fell -12.45% since last year same period to 34.53% in the Q4 2025. On a quarterly growth basis, CATALYST PHARMACEUTICALS INC has generated -2.92% fall in its net profit margins since last 3-months.

CATALYST PHARMACEUTICALS INC’s earning per share (EPS) estimates for the current quarter stand at 0.3 - a -9.7% fall from last quarter’s estimates.

CATALYST PHARMACEUTICALS INC’s earning per share (EPS) estimates for the current year stand at 0.3.

CATALYST PHARMACEUTICALS INC’s earning per share (EPS) jumped 54.55% since last year same period to 0.68 in the Q4 2025. This indicates that the CATALYST PHARMACEUTICALS INC has generated 54.55% annual rate of jump in its earning per share (EPS) in the last 4 quarters.